FDA Enforcement Class II Terminated

Blastomyces dermatitidis Antiserum 1 mL vial GIBSON BIOSCIENCE. Catalog 200265 Intended for identification of the systemic fungal pathogens.

Recall: Z-0606-2018 · Reported February 21, 2018

Enforcement

Recall Number
Z-0606-2018
Event ID
78731
Classification
Class II
Status
Terminated
Product Type
Devices
Firm
Gibson Laboratories LLC
Voluntary / Mandated
Voluntary: Firm initiated
Initial Notification
Letter
Report Date
February 21, 2018
Initiation Date
January 20, 2017
Classification Date
February 13, 2018
Termination Date
February 20, 2018
Address
1040 Manchester St, Lexington, KY, 40508-2422, United States

Description

Blastomyces dermatitidis Antiserum 1 mL vial GIBSON BIOSCIENCE. Catalog 200265 Intended for identification of the systemic fungal pathogens.

Reason

The firm information that the product was reporting false positive results

Code Info

Lot # 5072543 Exp Date 03/12/2021; UDI : 10634853000039.

Distribution

Distributed to the states of AL, AZ & MS.

Quantity

10/1 mL vials